Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models

Naohide Watanabe, Masayuki Nogawa, Mariko Ishiguro, Hitomi Maruyama, Masayuki Shiba, Masahiro Satake, Koji Eto, Makoto Handa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND: To bridge the gap between in vitro function and clinical efficacy of platelet (PLT) transfusion products, reliable in vivo PLT functional assays for hemostasis and survival in animal models are required. However, there are no standardized methods for assessing the in vivo quality of transfused human PLTs. STUDY DESIGN AND METHODS: Plasma-depleted human PLT concentrates (PCs; Day 3, Day 5, Day 7, Day 10, and damaged) were transfused into busulfan-induced rabbits with thrombocytopenia with prolonged bleeding times 1 day after treatment with ethyl palmitate (EP) to block their reticuloendothelial systems. The hemostatic effect of PC transfusion was evaluated by the ear fine vein bleeding time. For the in vivo survival assay, splenectomized EP-treated rabbits were transfused with human PCs, and viability of the human PLTs in the rabbits was determined by flow cytometry using human PLT-specific antibodies and Trucount tubes. RESULTS: The hemostatic effect of PCs was slightly reduced with increasing storage periods for early time points, but more dramatically reduced for later time points. PLT survival was similar after 3 and 7 days of storage, but PLTs stored for 10 days showed significantly poorer survival than those stored only 3 days. CONCLUSION: Our new and improved protocol for in vivo assessment of transfused PLTs is sufficiently sensitive to detect subtle changes in hemostatic function and viability of human PLTs transfused into rabbit models. This protocol could contribute to preclinical in vivo functional assessment and clinical quality assurance of emerging novel PLT products such as cultured cell–derived human PLTs.

Original languageEnglish
Pages (from-to)2035-2044
Number of pages10
JournalTransfusion
Volume57
Issue number8
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Hemostatics
Blood Platelets
Rabbits
Bleeding Time
Survival
Busulfan
Platelet Transfusion
Mononuclear Phagocyte System
Hemostasis
Thrombocytopenia
Ear
Veins
Flow Cytometry
Animal Models
Antibodies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Hematology

Cite this

Watanabe, N., Nogawa, M., Ishiguro, M., Maruyama, H., Shiba, M., Satake, M., ... Handa, M. (2017). Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models. Transfusion, 57(8), 2035-2044. https://doi.org/10.1111/trf.14189

Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models. / Watanabe, Naohide; Nogawa, Masayuki; Ishiguro, Mariko; Maruyama, Hitomi; Shiba, Masayuki; Satake, Masahiro; Eto, Koji; Handa, Makoto.

In: Transfusion, Vol. 57, No. 8, 01.08.2017, p. 2035-2044.

Research output: Contribution to journalArticle

Watanabe, N, Nogawa, M, Ishiguro, M, Maruyama, H, Shiba, M, Satake, M, Eto, K & Handa, M 2017, 'Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models', Transfusion, vol. 57, no. 8, pp. 2035-2044. https://doi.org/10.1111/trf.14189
Watanabe, Naohide ; Nogawa, Masayuki ; Ishiguro, Mariko ; Maruyama, Hitomi ; Shiba, Masayuki ; Satake, Masahiro ; Eto, Koji ; Handa, Makoto. / Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models. In: Transfusion. 2017 ; Vol. 57, No. 8. pp. 2035-2044.
@article{f0b8b9b34e284381a496a1fa0af2c5d6,
title = "Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models",
abstract = "BACKGROUND: To bridge the gap between in vitro function and clinical efficacy of platelet (PLT) transfusion products, reliable in vivo PLT functional assays for hemostasis and survival in animal models are required. However, there are no standardized methods for assessing the in vivo quality of transfused human PLTs. STUDY DESIGN AND METHODS: Plasma-depleted human PLT concentrates (PCs; Day 3, Day 5, Day 7, Day 10, and damaged) were transfused into busulfan-induced rabbits with thrombocytopenia with prolonged bleeding times 1 day after treatment with ethyl palmitate (EP) to block their reticuloendothelial systems. The hemostatic effect of PC transfusion was evaluated by the ear fine vein bleeding time. For the in vivo survival assay, splenectomized EP-treated rabbits were transfused with human PCs, and viability of the human PLTs in the rabbits was determined by flow cytometry using human PLT-specific antibodies and Trucount tubes. RESULTS: The hemostatic effect of PCs was slightly reduced with increasing storage periods for early time points, but more dramatically reduced for later time points. PLT survival was similar after 3 and 7 days of storage, but PLTs stored for 10 days showed significantly poorer survival than those stored only 3 days. CONCLUSION: Our new and improved protocol for in vivo assessment of transfused PLTs is sufficiently sensitive to detect subtle changes in hemostatic function and viability of human PLTs transfused into rabbit models. This protocol could contribute to preclinical in vivo functional assessment and clinical quality assurance of emerging novel PLT products such as cultured cell–derived human PLTs.",
author = "Naohide Watanabe and Masayuki Nogawa and Mariko Ishiguro and Hitomi Maruyama and Masayuki Shiba and Masahiro Satake and Koji Eto and Makoto Handa",
year = "2017",
month = "8",
day = "1",
doi = "10.1111/trf.14189",
language = "English",
volume = "57",
pages = "2035--2044",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models

AU - Watanabe, Naohide

AU - Nogawa, Masayuki

AU - Ishiguro, Mariko

AU - Maruyama, Hitomi

AU - Shiba, Masayuki

AU - Satake, Masahiro

AU - Eto, Koji

AU - Handa, Makoto

PY - 2017/8/1

Y1 - 2017/8/1

N2 - BACKGROUND: To bridge the gap between in vitro function and clinical efficacy of platelet (PLT) transfusion products, reliable in vivo PLT functional assays for hemostasis and survival in animal models are required. However, there are no standardized methods for assessing the in vivo quality of transfused human PLTs. STUDY DESIGN AND METHODS: Plasma-depleted human PLT concentrates (PCs; Day 3, Day 5, Day 7, Day 10, and damaged) were transfused into busulfan-induced rabbits with thrombocytopenia with prolonged bleeding times 1 day after treatment with ethyl palmitate (EP) to block their reticuloendothelial systems. The hemostatic effect of PC transfusion was evaluated by the ear fine vein bleeding time. For the in vivo survival assay, splenectomized EP-treated rabbits were transfused with human PCs, and viability of the human PLTs in the rabbits was determined by flow cytometry using human PLT-specific antibodies and Trucount tubes. RESULTS: The hemostatic effect of PCs was slightly reduced with increasing storage periods for early time points, but more dramatically reduced for later time points. PLT survival was similar after 3 and 7 days of storage, but PLTs stored for 10 days showed significantly poorer survival than those stored only 3 days. CONCLUSION: Our new and improved protocol for in vivo assessment of transfused PLTs is sufficiently sensitive to detect subtle changes in hemostatic function and viability of human PLTs transfused into rabbit models. This protocol could contribute to preclinical in vivo functional assessment and clinical quality assurance of emerging novel PLT products such as cultured cell–derived human PLTs.

AB - BACKGROUND: To bridge the gap between in vitro function and clinical efficacy of platelet (PLT) transfusion products, reliable in vivo PLT functional assays for hemostasis and survival in animal models are required. However, there are no standardized methods for assessing the in vivo quality of transfused human PLTs. STUDY DESIGN AND METHODS: Plasma-depleted human PLT concentrates (PCs; Day 3, Day 5, Day 7, Day 10, and damaged) were transfused into busulfan-induced rabbits with thrombocytopenia with prolonged bleeding times 1 day after treatment with ethyl palmitate (EP) to block their reticuloendothelial systems. The hemostatic effect of PC transfusion was evaluated by the ear fine vein bleeding time. For the in vivo survival assay, splenectomized EP-treated rabbits were transfused with human PCs, and viability of the human PLTs in the rabbits was determined by flow cytometry using human PLT-specific antibodies and Trucount tubes. RESULTS: The hemostatic effect of PCs was slightly reduced with increasing storage periods for early time points, but more dramatically reduced for later time points. PLT survival was similar after 3 and 7 days of storage, but PLTs stored for 10 days showed significantly poorer survival than those stored only 3 days. CONCLUSION: Our new and improved protocol for in vivo assessment of transfused PLTs is sufficiently sensitive to detect subtle changes in hemostatic function and viability of human PLTs transfused into rabbit models. This protocol could contribute to preclinical in vivo functional assessment and clinical quality assurance of emerging novel PLT products such as cultured cell–derived human PLTs.

UR - http://www.scopus.com/inward/record.url?scp=85021847335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021847335&partnerID=8YFLogxK

U2 - 10.1111/trf.14189

DO - 10.1111/trf.14189

M3 - Article

VL - 57

SP - 2035

EP - 2044

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 8

ER -